Thierry LEVADE, MD, PhD
born July 4, 1957 in Rabastens, France, married, two children
PU-PH, Professor of Biochemistry and Molecular Biology, Toulouse-Rangueil Medical School
Current position: PI of ‘Sphingolipids, Cell Death and Tumor progression’ Group,
INSERM Unit 1037, Rangueil Hospital, 31432 Toulouse, France
1982: MD (Médaille d’or), University of Toulouse, France
1983: Department of chemical pathology, Hospital of Toulouse,
1984: Visiting Fellow, dept of neurochemistry and membrane biochemistry (Prof. S. Gatt), Hebrew University, Jerusalem, Israel
1986: Visiting Fellow, Division of Medical Genetics (Prof. Robert J. Desnick), Mount Sinai Hospital, New York
1986: PhD biochemistry, University of Toulouse, France
1987: Chargé de Recherche, INSERM Unit 101 (Profs. L. Douste-Blazy and H. Chap), Toulouse, France
1992: HDR, University of Toulouse, France
1993: Research Director, INSERM U.466 (Prof. R. Salvayre), Toulouse, France; PI of ‘Sphingolipids: signaling and lipidoses’ Group
2000: Full Professor of Biochemistry and Molecular Biology, Medical School, University of Toulouse, France
2006: PI of ‘Sphingolipids, cell death and disease’ group, INSERM U.858 (Dir. A. Parini) Hospital of Rangueil, Toulouse, France
2011: PI of ‘Sphingolipids, cell death and tumor progression’ group, INSERM UMR1037 (Dir. JJ. Fournie) Hospital of Rangueil, Toulouse, France
Teaching activities
Paul Sabatier University of Toulouse, France
1997-present Lecturing in Biochemistry, Medical School (1st, 2nd and 3rd years)
1997-present Lecturing in Molecular Biology, Medical School (1st and 3rd years)
1991-present Lecturing in Human Pathophysiology, Biochemistry, Cellular Pharmacology, Cellular Physiology (Master’s and Postgraduate degrees), Universities of Toulouse, Angers, Paris, and Bordeaux, France
Other functions
M.D. at C.H.U. Hospital of Toulouse, Department of Chemical Pathology: since Jan. 1983
Honors and awards
1982 Lauréat de la Faculté de Médecine de Toulouse, Médaille d'Or
1987 Lauréat de l'Académie Nationale de Médecine
Main Research interests
Sphingolipid metabolism, Lysosomal storage diseases
Reviewing and editorial activities
- Reviewer for: J. Clin. Invest., J. Biol. Chem., FASEB J., PNAS, J. Cell Biol., Circ. Res., Cell Death Differ., Exp. Cell Res., Biochem. J., BBA, J. Neurochem., Am. J. Physiol., FEBS Lett., …
- Editor : Biochim. Biophys. Acta - Mol. Cell Biol. Lipids (Section Editor), Biochem. J. (editorial adviser)
- Reviewer for scientific committees of foundations: Action Research, USA-Israel Binational Science Foundation, Italian Ministry Program, The Netherlands Cancer Institute, MRC, INSERM, DFG, Italian Telethon, German Israeli Foundation,...
In order to better understand the molecular mechanisms that regulate cell death, we are analysing the effects and modes of action of sphingolipids (and of the enzymes/proteins which control sphingolipid metabolism and trafficking) in the modulation of cell death
pathways. Hence, our project aims at defining novel targets in lipid metabolism able to interfere with cell death programs and, consequently, to halt tumor progression.
Keywords
Sphingolipids, apoptosis, ceramide, metabolism, caspases, melanoma, leukemia, chemotherapy, tumor microenvironment.